Olema Pharmaceuticals Inc (OLMA)

Apr 03, 2025

HighTower Advisors LLC Makes New $510,000 Investment in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Apr 03, 2025

Apr 03, 2025

10,352 Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Bought by Teacher Retirement System of Texas - Defense World

Apr 03, 2025

Apr 02, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 02, 2025

Apr 02, 2025

Olema Expands Team: 5 Key Hires Receive Equity Compensation Package - Stock Titan

Apr 02, 2025

Apr 01, 2025

Top Premarket Decliners - MarketScreener

Apr 01, 2025

Apr 01, 2025

Insiders Could Have Profited By Holding onto Olema Pharmaceuticals Shares Despite 13% Drop - simplywall.st

Apr 01, 2025

Mar 31, 2025

Olema Pharmaceuticals stock hits 52-week low at $3.86 By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Olema Pharmaceuticals stock hits 52-week low at $3.86 - Investing.com

Mar 31, 2025

Mar 31, 2025

HighTower Advisors LLC Takes $510,000 Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Mar 31, 2025

Mar 31, 2025

JPMorgan Chase & Co. Lowers Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28.00 - MarketBeat

Mar 31, 2025

Mar 29, 2025

Pier Capital LLC Acquires New Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Mar 29, 2025

Mar 27, 2025

Bank of New York Mellon Corp Trims Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Mar 27, 2025

Mar 26, 2025

Olema Oncology to Present Preclinical Data for OP-3136, a - GlobeNewswire

Mar 26, 2025

Mar 25, 2025

Victory Capital Management Inc. Cuts Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Mar 25, 2025

Mar 25, 2025

Cancer Breakthrough: New Drug Shows Powerful Anti-Tumor Effects in Prostate, Ovarian, Lung Cancers - Stock Titan

Mar 25, 2025

Mar 25, 2025

What is Lifesci Capital's Estimate for OLMA FY2025 Earnings? - MarketBeat

Mar 25, 2025

Mar 25, 2025

HC Wainwright Has Positive Forecast for OLMA Q1 Earnings - MarketBeat

Mar 25, 2025

Mar 24, 2025

What is HC Wainwright's Forecast for OLMA FY2029 Earnings? - MarketBeat

Mar 24, 2025

Mar 23, 2025

Olema Pharmaceuticals' (OLMA) "Outperform" Rating Reiterated at Oppenheimer - MarketBeat

Mar 23, 2025

Mar 23, 2025

HC Wainwright Reaffirms "Buy" Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat

Mar 23, 2025

Mar 23, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Releases Earnings Results - MarketBeat

Mar 23, 2025

Mar 22, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Posts Quarterly Earnings Results, Beats Estimates By $0.12 EPS - MarketBeat

Mar 22, 2025

Mar 22, 2025

Victory Capital Management Inc. Sells 758,412 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Mar 22, 2025

Mar 22, 2025

HC Wainwright Issues Optimistic Outlook for OLMA Earnings - Defense World

Mar 22, 2025

Mar 22, 2025

FY2025 EPS Estimate for Olema Pharmaceuticals Cut by Analyst - Defense World

Mar 22, 2025

Mar 21, 2025

Olema Pharmaceuticals Inc (OLMA) Shares Rise Despite Market Challenges - The News Heater

Mar 21, 2025

Mar 21, 2025

Olema Oncology Reports 2024 Financial and Clinical Progress - TipRanks

Mar 21, 2025

Mar 21, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Earns “Outperform” Rating from Oppenheimer - Defense World

Mar 21, 2025

Mar 21, 2025

What is HC Wainwright’s Forecast for OLMA FY2029 Earnings? - Defense World

Mar 21, 2025

Mar 21, 2025

HC Wainwright Reiterates “Buy” Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - Defense World

Mar 21, 2025

Mar 20, 2025

Olema Pharmaceuticals stock hits 52-week low at $3.94 By Investing.com - Investing.com Australia

Mar 20, 2025

Mar 20, 2025

Olema Pharmaceuticals stock hits 52-week low at $3.94 - Investing.com India

Mar 20, 2025

Mar 19, 2025

Olema Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 19, 2025

Mar 18, 2025

Olema Oncology Reports Fourth Quarter and Full Year 2024 Financial and Operating Results - GlobeNewswire

Mar 18, 2025

Mar 18, 2025

Olema Oncology price target lowered to $25 from $30 at Oppenheimer - TipRanks

Mar 18, 2025

Mar 18, 2025

Olema Pharmaceuticals Q4 Net Loss Widens -March 18, 2025 at 04:37 pm EDT - Marketscreener.com

Mar 18, 2025

Mar 18, 2025

Olema Pharmaceuticals Inc Reports Q4 2024 EPS of -$0.63 and Net - GuruFocus.com

Mar 18, 2025

Mar 18, 2025

Olema Pharmaceuticals, Inc. SEC 10-K Report - TradingView

Mar 18, 2025

Mar 17, 2025

Olema Pharmaceuticals Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView

Mar 17, 2025